ISET Company Profile

21:47 EDT 23rd June 2018 | BioPortfolio

News Articles [0 Results]


Drugs and Medications [0 Results]


PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

High-purity capture of CTCs based on micro-beads enhanced isolation by size of epithelial tumor cells (ISET) method.

In this paper, we develop a low-cost size-based microfluidic chip using conventional polycarbonate membrane to isolate CTCs from blood, and propose a strategy to increase the capture efficiency before...

Clinical Trials [6 Associated Clinical Trials listed on BioPortfolio]

The Method ISET (Insulation by Size of Epithelial Tumor Cells)

The aim of this study is, i) to assess the presence and the frequency of CTC in NSCLC patients undergoing surgery by using cytopathological analysis after their isolation by size (ISET met...

Kinetics of Circulating Tumoral Cells in Bronchial Primitive Cancer

The pronostic value of Circulating Tumoral Cells(CTC) 's dosage by the method ISET® (tumoral cell isolation by size) in patients with bronchial cancer was previously demonstrated. Howeve...

Islet Transplantation in Type 1 Diabetic Patients Using the University of Illinois at Chicago (UIC) Protocol

In an earlier Phase 1/2 clinical trial using the Edmonton Protocol of steroid free immunosuppression, investigators at University of Illinois at Chicago (UIC) demonstrated the safety of is...

Application of Detecting Circulating Tumor Cells in the Accurate Treatment of Early Stage Lung Adenocarcinoma

In 2015-2016, 224,390 cases were newly diagnosed with lung cancer in USA. Of all the cases, 83% are non-small cell lung cancer (NSCLC). Currently, the 5-year survival rate of NSCLC patient...

Circulating Tumor Cells in Lung Cancer Screening

This trial is intended to evaluate the value of circulating tumor cells (CTC), in combination with unenhanced (without injection of contrast media) low dose (to limit the effective radiati...

Companies [3 Associated Companies listed on BioPortfolio]

International Symposium on Endovascular Therapy

Begun in 1989 and led by acclaimed interventionist Barry Katzen, M.D., ISET is attended annually by physicians, scientists, allied health professionals and industry professionals ...



Rarecells® was founded in 2009 by Patrizia Paterlini-Brechot MD, PhD, Professor of Cell Biology and Oncology at University Paris Descartes Paris, France, to validate and commer...

More Information about "ISET" on BioPortfolio

We have published hundreds of ISET news stories on BioPortfolio along with dozens of ISET Clinical Trials and PubMed Articles about ISET for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ISET Companies in our database. You can also find out about relevant ISET Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record